Quantum Cyber (QUCY) EBT Margin (2022 - 2023)
Quantum Cyber (QUCY) posted EBT Margin of 2413.53% for Q4 2023, up 30.4% sequentially from 3467.71% in Q3 2023, and up 182313.0% YoY from N/an in Q4 2022.
Quantum Cyber (QUCY) EBT Margin (2022 - 2023) Analysis & Trends
Quantum Cyber has reported EBT Margin for 2 years, with the latest figure at 2413.53% in Q4 2023.
- Quarterly EBT Margin rose 182313.0% year-over-year to 2413.53% in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 2936.5% (up 204340.0% YoY) and the FY2025 annual result came in at 3018.31%, down 60231.0% from the prior year.
- EBT Margin grew to 2413.53% in Q4 2023 per QUCY's latest filing, from 3467.71% in the prior quarter.
- Over five years, EBT Margin peaked at 2413.53% in Q4 2023 and troughed at 5781.76% in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 16.04% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 17.21% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -8.93% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 22.23% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 6.89% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 34.29% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 22.43% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 28.17% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 10.36% |
| 10 | Quantum Cyber | 26.42 Mn | 12.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | -3,467.71% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -2,623.28% |
| Dec 31, 2022 | -27,703.71% |
| Sep 30, 2022 | -5,781.76% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | -5,631.92% |